CD44 and breast carcinoma: Studies show that CD44, a hyaluronic acid (HA) binding transmembrane glycoprotein, forms a complex with the nonintegral cell surface protein RHAMM [89–92] to promote tumor cell migration [93,94], and both may be upregulated in breast cancer [95,96].